Literature DB >> 72725

Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils.

G Camussi, J M Mencia-Huerta, J Benveniste.   

Abstract

Immune complexes (ICs) triggered the degranulation of basophils/mastocytes in rabbit and man, thus releasing histamine and platelet-activating-factor. ICs acted upon basophils/mastocytes through complement activation and generation of anaphylatoxins and through release of cationic proteins from polymorphonuclear neutrophils. Anaphylatoxins and cationic proteins were active on human and rabbit mastocytes and on human basophils but not on rabbit basophils. Therefore, a cascade of cell to cell interactions may be envisaged implicating successively neutrophils, basophils and/or mastocytes and platelets. These interactions result in enhanced vascular permeability that allows ICs to be trapped along filtering basement membranes. This sequence could perpetuate the deposition of ICs, initially triggered by degranulation of basophils and mastocytes through the IgE-dependent mechanism, and furnish us with an explanation for the rather poorly understood involvement of platelets in immunopathology.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72725      PMCID: PMC1445400     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Leukocyte preparations from human blood: evaluation of their morphologic and metabolic state.

Authors:  H J FALLON; E FREI; J D DAVIDSON; J S TRIER; D BURK
Journal:  J Lab Clin Med       Date:  1962-05

2.  Evidence for the involvement of IgE-basophil system in acute serum sickness.

Authors:  J Benveniste; J Egido; V Gutierrez-Millet
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

3.  Two distinct mechanisms for the initiation of mast cell degranulation.

Authors:  D C Morrison; J F Roser; C G Cochrane; P M Henson
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

4.  Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils.

Authors:  J Benveniste
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

5.  Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells.

Authors:  I Olsson; P Venge
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

6.  Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction.

Authors:  R P Siraganian; W A Hook
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

7.  Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.

Authors:  P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

8.  Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

Authors:  E H Vallota; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

9.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  24 in total

1.  Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: antagonism by BN-52021.

Authors:  F Berti; G Rossoni; P Braquet
Journal:  Agents Actions       Date:  1990-06

2.  Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells.

Authors:  T Dohi; K Morita; S Kitayama; A Tsujimoto
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

Authors:  G Camussi; M Aglietta; R Coda; F Bussolino; W Piacibello; C Tetta
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

Review 4.  Cationic polyelectrolytes: a new look at their possible roles as opsonins, as stimulators of respiratory burst in leukocytes, in bacteriolysis, and as modulators of immune-complex diseases (a review hypothesis).

Authors:  I Ginsburg
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

Review 5.  Platelet-activating factor and the cytokine network in inflammatory processes.

Authors:  B Bonavida; J M Mencia-Huerta
Journal:  Clin Rev Allergy       Date:  1994

6.  Platelet activating factor: an inhibitor of neutrophil activation?

Authors:  M C O'Donnell; J N Siegel; B A Fiedel
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.

Authors:  R Huey; C M Bloor; M S Kawahara; T E Hugli
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

8.  Immune complexes and the pathogenesis of neutropenia in Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E de Vries; J H van Krieken; A Cats
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

9.  Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes.

Authors:  G Virella; M F Lopes-Virella; C Shuler; T Sherwood; G A Espinoza; P Winocour; J A Colwell
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

10.  Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.

Authors:  G Montrucchio; G Alloatti; F Mariano; A Comino; G Cacace; R Polloni; P G De Filippi; G Emanuelli; G Camussi
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.